![](https://monteverdelaw.com/wp-content/uploads/case-logo/spring-bank-pharmaceuticals-inc.jpg)
Spring Bank Pharmaceuticals, Inc. (SBPH) related to its agreement to acquire F-star Therapeutics Limited. Under the terms of the agreement, shareholders of Spring Bank will own approximately 38.8% of the combined company while F-star holders will own approximately 61.2% of the combined company.